| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2124815 | European Journal of Cancer | 2006 | 5 Pages |
Abstract
In conclusion, this study demonstrates a low risk of developing peripartum A-CHF in childhood cancer survivors. However, more cohort studies with adequate power and long-term follow-up are needed to reliably evaluate the cumulative incidence of peripartum anthracycline-induced cardiotoxicity (both clinical and asymptomatic) and associated risk factors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Elvira C. van Dalen, Helena J.H. van der Pal, Cor van den Bos, Wouter E.M. Kok, Huib N. Caron, Leontien C.M. Kremer,